HEADER ANTIBIOTIC 08-JUN-11 3ZQ8 TITLE STRUCTURE OF LINEAR GRAMICIDIN D OBTAINED USING TYPE I CRYSTALS GROWN TITLE 2 IN A MONOVACCENIN LIPID CUBIC PHASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: VAL-GRAMICIDIN A; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: GRAMICIDIN D SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BREVIBACILLUS BREVIS; SOURCE 3 ORGANISM_TAXID: 1393; SOURCE 4 ATCC: 8246 KEYWDS ANTIBIOTIC, ION CHANNEL, MESOPHASE EXPDTA X-RAY DIFFRACTION AUTHOR N.HOEFER,D.ARAGAO,M.CAFFREY REVDAT 5 07-FEB-24 3ZQ8 1 REMARK REVDAT 4 15-NOV-23 3ZQ8 1 LINK ATOM REVDAT 3 29-MAR-23 3ZQ8 1 AUTHOR REMARK REVDAT 2 06-MAR-19 3ZQ8 1 REMARK LINK REVDAT 1 18-JUL-12 3ZQ8 0 JRNL AUTH N.HOEFER,D.ARAGAO,M.CAFFREY JRNL TITL CRYSTALLIZATION OF GRAMICIDIN FROM A MONOVACCENIN LIPIDIC JRNL TITL 2 CUBIC PHASE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 3 NUMBER OF REFLECTIONS : 6306 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.168 REMARK 3 R VALUE (WORKING SET) : 0.166 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.600 REMARK 3 FREE R VALUE TEST SET COUNT : 306 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.75 REMARK 3 REFLECTION IN BIN (WORKING SET) : 352 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 78.91 REMARK 3 BIN R VALUE (WORKING SET) : 0.2000 REMARK 3 BIN FREE R VALUE SET COUNT : 26 REMARK 3 BIN FREE R VALUE : 0.2420 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 544 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 44 REMARK 3 SOLVENT ATOMS : 2 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.28 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.02000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : -0.05000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.03000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.119 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.117 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.066 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.994 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.963 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.924 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 664 ; 0.019 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 906 ; 1.828 ; 1.904 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 64 ; 5.934 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 18 ;28.113 ;20.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 27 ;13.357 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 101 ; 0.158 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 440 ; 0.017 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 337 ; 1.646 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 521 ; 2.600 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 327 ; 3.480 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 382 ; 5.062 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 3ZQ8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-JUN-11. REMARK 100 THE DEPOSITION ID IS D_1290048031. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-OCT-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.93950 REMARK 200 MONOCHROMATOR : CHANNEL-CUT DOUBLE-CRYSTAL REMARK 200 SILICON 111 REMARK 200 OPTICS : TOROIDAL MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6612 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 22.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 23.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.75 REMARK 200 COMPLETENESS FOR SHELL (%) : 78.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.25000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2XDC REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1M LITHIUM SULFATE, 10 MM NICKEL REMARK 280 CHLORIDE, 0.1 M TRIS HCL, PH 8.5, LIPIDIC CUBIC PHASE OF REMARK 280 MONOVACCENIN (11.7 MAG) REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 20.99050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7450 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 4610 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -55.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 GRAMICIDIN IS A HETEROGENEOUS MIXTURE OF SEVERAL COMPOUNDS REMARK 400 INCLUDING GRAMICIDIN A, B AND C WHICH ARE OBTAINED FROM REMARK 400 BACILLUS BREVIS AND COLLECTIVELY CALLED GRAMICIDIN D REMARK 400 HERE, GRAMICIDIN A IS REPRESENTED BY THE SEQUENCE (SEQRES) REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: GRAMICIDIN A REMARK 400 CHAIN: A, B, C, D, E, F REMARK 400 COMPONENT_1: PEPTIDE LIKE SEQUENCE RESIDUES 1 TO 16 REMARK 400 DESCRIPTION: GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE REMARK 400 WITH ALTERNATING D,L CHARACTERISTICS. REMARK 400 THE N-TERM IS FORMYLATED (RESIDUE 1) WITH REMARK 400 ETHANOLAMINE AT THE C-TERM (RESIDUE 16) REMARK 400 REMARK 400 THE GRAMICIDIN A IS POLYPEPTIDE, A MEMBER OF ANTIBIOTIC CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: GRAMICIDIN A REMARK 400 CHAIN: A, B, C, D REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE WITH REMARK 400 ALTERNATING D,L CHARACTERISTICS. THE N-TERM IS REMARK 400 FORMYLATED (RESIDUE 0). THE C-TERM IS CAPPED WITH REMARK 400 ETHANOLAMINE (RESIDUE 16). REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TRP B 15 O - C - N ANGL. DEV. = 10.1 DEGREES REMARK 500 ETA B 16 C - N - CA ANGL. DEV. = -19.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 5 87.37 -153.90 REMARK 500 TRP A 11 90.07 -161.78 REMARK 500 TRP A 13 88.96 -156.97 REMARK 500 TRP A 15 81.98 -164.40 REMARK 500 TRP B 13 86.09 -158.06 REMARK 500 TRP C 11 78.41 -159.47 REMARK 500 TRP C 13 88.35 -159.17 REMARK 500 TRP C 15 95.40 -163.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 MVC C 1016 REMARK 610 MVC C 1017 REMARK 610 MVC C 1018 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MVC C 1016 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MVC C 1017 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MVC C 1018 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1NT6 RELATED DB: PDB REMARK 900 F1-GRAMICIDIN C IN SODIUM DODECYL SULFATE MICELLES (NMR) REMARK 900 RELATED ID: 1JO3 RELATED DB: PDB REMARK 900 GRAMICIDIN B IN SODIUM DODECYL SULFATE MICELLES (NMR) REMARK 900 RELATED ID: 1ALZ RELATED DB: PDB REMARK 900 GRAMICIDIN D FROM BACILLUS BREVIS (ETHANOL SOLVATE) REMARK 900 RELATED ID: 1GRM RELATED DB: PDB REMARK 900 GRAMICIDIN A (NMR, 5 STRUCTURES) REMARK 900 RELATED ID: 1JO4 RELATED DB: PDB REMARK 900 GRAMICIDIN C IN SODIUM DODECYL SULFATE MICELLES (NMR) REMARK 900 RELATED ID: 1BDW RELATED DB: PDB REMARK 900 GRAMICIDIN D FROM BACILLUS BREVIS (ACTIVE FORM) REMARK 900 RELATED ID: 1NRU RELATED DB: PDB REMARK 900 GRAMICIDIN A IN DODECYL PHOSPHOCHOLINE MICELLES IN THEPRESENCE OF REMARK 900 EXCESS NA+ (NMR) REMARK 900 RELATED ID: 1W5U RELATED DB: PDB REMARK 900 GRAMICIDIN D FROM BACILLUS BREVIS (ETHANOL SOLVATE) REMARK 900 RELATED ID: 1TKQ RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF A LINKED UNSYMMETRIC GRAMICIDIN IN AMEMBRANE- REMARK 900 ISOELECTRICAL SOLVENTS MIXTURE IN THE PRESENCE OFCSCL REMARK 900 RELATED ID: 1MAG RELATED DB: PDB REMARK 900 GRAMICIDIN A IN HYDRATED DMPC BILAYERS, SOLID STATE NMR REMARK 900 RELATED ID: 2IZQ RELATED DB: PDB REMARK 900 GRAMICIDIN D COMPLEX WITH KI REMARK 900 RELATED ID: 1C4D RELATED DB: PDB REMARK 900 GRAMICIDIN CSCL COMPLEX REMARK 900 RELATED ID: 1AV2 RELATED DB: PDB REMARK 900 GRAMICIDIN A/CSCL COMPLEX, ACTIVE AS A DIMER REMARK 900 RELATED ID: 1KQE RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF A LINKED SHORTENED GRAMICIDIN A INBENZENE/ REMARK 900 ACETONE 10:1 REMARK 900 RELATED ID: 1MIC RELATED DB: PDB REMARK 900 GRAMICIDIN A: LEFT-HANDED PARALLEL DOUBLE HELICAL FORM IN METHANOL REMARK 900 IN THE PRESENCE OF CACL2, NMR, 20 STRUCTURES REMARK 900 RELATED ID: 1NT5 RELATED DB: PDB REMARK 900 F1-GRAMICIDIN A IN SODIUM DODECYL SULFATE MICELLES (NMR) REMARK 900 RELATED ID: 1AL4 RELATED DB: PDB REMARK 900 GRAMICIDIN D FROM BACILLUS BREVIS (N- PROPANOL SOLVATE) REMARK 900 RELATED ID: 1GMK RELATED DB: PDB REMARK 900 GRAMICIDIN/KSCN COMPLEX REMARK 900 RELATED ID: 1NG8 RELATED DB: PDB REMARK 900 G15-GRAMICIDIN A IN SODIUM DODECYL SULFATE MICELLES (NMR) REMARK 900 RELATED ID: 1NRM RELATED DB: PDB REMARK 900 GRAMICIDIN A IN DODECYL PHOSPHOCHOLINE MICELLES (NMR) REMARK 900 RELATED ID: 1JNO RELATED DB: PDB REMARK 900 GRAMICIDIN A IN SODIUM DODECYL SULFATE MICELLES (NMR) REMARK 900 RELATED ID: 1ALX RELATED DB: PDB REMARK 900 GRAMICIDIN D FROM BACILLUS BREVIS (METHANOL SOLVATE) REMARK 900 RELATED ID: 2XDC RELATED DB: PDB REMARK 900 STRUCTURE OF LINEAR GRAMICIDIN D OBTAINED USING TYPE I CRYSTALS REMARK 900 GROWN IN A LIPID CUBIC PHASE. REMARK 900 RELATED ID: 2Y6N RELATED DB: PDB REMARK 900 STRUCTURE OF LINEAR GRAMICIDIN D OBTAINED USING TYPE I CRYSTALS REMARK 900 GROWN IN A 8.8 MONOACYLGLYCEROL LIPID CUBIC PHASE. REMARK 900 RELATED ID: 2Y5M RELATED DB: PDB REMARK 900 STRUCTURE OF LINEAR GRAMICIDIN D OBTAINED USING TYPE I CRYSTALS REMARK 900 GROWN IN A 7.7 MONOACYLGLYCEROL LIPID CUBIC PHASE. DBREF 3ZQ8 A 1 16 NOR NOR00243 NOR00243 1 16 DBREF 3ZQ8 B 1 16 NOR NOR00243 NOR00243 1 16 DBREF 3ZQ8 C 1 16 NOR NOR00243 NOR00243 1 16 DBREF 3ZQ8 D 1 16 NOR NOR00243 NOR00243 1 16 SEQRES 1 A 16 FVA GLY ALA DLE ALA DVA VAL DVA TRP DLE TRP DLE TRP SEQRES 2 A 16 DLE TRP ETA SEQRES 1 B 16 FVA GLY ALA DLE ALA DVA VAL DVA TRP DLE TRP DLE TRP SEQRES 2 B 16 DLE TRP ETA SEQRES 1 C 16 FVA GLY ALA DLE ALA DVA VAL DVA TRP DLE TRP DLE TRP SEQRES 2 C 16 DLE TRP ETA SEQRES 1 D 16 FVA GLY ALA DLE ALA DVA VAL DVA TRP DLE TRP DLE TRP SEQRES 2 D 16 DLE TRP ETA MODRES 3ZQ8 FVA A 1 VAL N-FORMYL-L-VALINE MODRES 3ZQ8 FVA B 1 VAL N-FORMYL-L-VALINE MODRES 3ZQ8 FVA C 1 VAL N-FORMYL-L-VALINE MODRES 3ZQ8 FVA D 1 VAL N-FORMYL-L-VALINE HET FVA A 1 9 HET DLE A 4 8 HET DVA A 6 11 HET DVA A 8 7 HET DLE A 10 8 HET DLE A 12 8 HET DLE A 14 8 HET ETA A 16 4 HET FVA B 1 9 HET DLE B 4 8 HET DVA B 6 11 HET DVA B 8 7 HET DLE B 10 8 HET DLE B 12 8 HET DLE B 14 8 HET ETA B 16 4 HET FVA C 1 9 HET DLE C 4 8 HET DVA C 6 7 HET DVA C 8 10 HET DLE C 10 8 HET DLE C 12 8 HET DLE C 14 8 HET ETA C 16 4 HET FVA D 1 9 HET DLE D 4 8 HET DVA D 6 7 HET DVA D 8 7 HET DLE D 10 8 HET DLE D 12 8 HET DLE D 14 8 HET ETA D 16 8 HET MVC C1016 23 HET MVC C1017 11 HET MVC C1018 10 HETNAM FVA N-FORMYL-L-VALINE HETNAM DLE D-LEUCINE HETNAM DVA D-VALINE HETNAM ETA ETHANOLAMINE HETNAM MVC MONOVACCENIN HETSYN MVC 11.7 MAG FORMUL 1 FVA 4(C6 H11 N O3) FORMUL 1 DLE 16(C6 H13 N O2) FORMUL 1 DVA 8(C5 H11 N O2) FORMUL 1 ETA 4(C2 H7 N O) FORMUL 5 MVC 3(C21 H40 O4) FORMUL 8 HOH *2(H2 O) SHEET 1 AA 2 ALA A 3 DLE A 14 0 SHEET 2 AA 2 ALA B 3 DLE B 14 -1 O ALA B 3 N TRP A 13 SHEET 1 CA 2 ALA C 3 DLE C 14 0 SHEET 2 CA 2 ALA D 3 DLE D 14 -1 O ALA D 3 N TRP C 13 LINK C FVA A 1 N GLY A 2 1555 1555 1.33 LINK C ALA A 3 N DLE A 4 1555 1555 1.34 LINK C DLE A 4 N ALA A 5 1555 1555 1.33 LINK C ALA A 5 N DVA A 6 1555 1555 1.33 LINK C DVA A 6 N VAL A 7 1555 1555 1.32 LINK C VAL A 7 N DVA A 8 1555 1555 1.34 LINK C DVA A 8 N TRP A 9 1555 1555 1.35 LINK C TRP A 9 N DLE A 10 1555 1555 1.33 LINK C DLE A 10 N TRP A 11 1555 1555 1.34 LINK C TRP A 11 N DLE A 12 1555 1555 1.34 LINK C DLE A 12 N TRP A 13 1555 1555 1.33 LINK C TRP A 13 N DLE A 14 1555 1555 1.32 LINK C DLE A 14 N TRP A 15 1555 1555 1.33 LINK C TRP A 15 N ETA A 16 1555 1555 1.32 LINK C FVA B 1 N GLY B 2 1555 1555 1.34 LINK C ALA B 3 N DLE B 4 1555 1555 1.32 LINK C DLE B 4 N ALA B 5 1555 1555 1.33 LINK C ALA B 5 N DVA B 6 1555 1555 1.31 LINK C DVA B 6 N VAL B 7 1555 1555 1.33 LINK C VAL B 7 N DVA B 8 1555 1555 1.33 LINK C DVA B 8 N TRP B 9 1555 1555 1.33 LINK C TRP B 9 N DLE B 10 1555 1555 1.34 LINK C DLE B 10 N TRP B 11 1555 1555 1.34 LINK C TRP B 11 N DLE B 12 1555 1555 1.33 LINK C DLE B 12 N TRP B 13 1555 1555 1.33 LINK C TRP B 13 N DLE B 14 1555 1555 1.34 LINK C DLE B 14 N TRP B 15 1555 1555 1.33 LINK C TRP B 15 N ETA B 16 1555 1555 1.32 LINK C FVA C 1 N GLY C 2 1555 1555 1.31 LINK C ALA C 3 N DLE C 4 1555 1555 1.32 LINK C DLE C 4 N ALA C 5 1555 1555 1.34 LINK C ALA C 5 N DVA C 6 1555 1555 1.33 LINK C DVA C 6 N VAL C 7 1555 1555 1.31 LINK C VAL C 7 N DVA C 8 1555 1555 1.32 LINK C DVA C 8 N TRP C 9 1555 1555 1.34 LINK C TRP C 9 N DLE C 10 1555 1555 1.35 LINK C DLE C 10 N TRP C 11 1555 1555 1.33 LINK C TRP C 11 N DLE C 12 1555 1555 1.33 LINK C DLE C 12 N TRP C 13 1555 1555 1.36 LINK C TRP C 13 N DLE C 14 1555 1555 1.33 LINK C DLE C 14 N TRP C 15 1555 1555 1.32 LINK C TRP C 15 N ETA C 16 1555 1555 1.33 LINK C FVA D 1 N GLY D 2 1555 1555 1.34 LINK C ALA D 3 N DLE D 4 1555 1555 1.33 LINK C DLE D 4 N ALA D 5 1555 1555 1.33 LINK C ALA D 5 N DVA D 6 1555 1555 1.32 LINK C DVA D 6 N VAL D 7 1555 1555 1.33 LINK C VAL D 7 N DVA D 8 1555 1555 1.34 LINK C DVA D 8 N TRP D 9 1555 1555 1.33 LINK C TRP D 9 N DLE D 10 1555 1555 1.33 LINK C DLE D 10 N TRP D 11 1555 1555 1.34 LINK C TRP D 11 N DLE D 12 1555 1555 1.32 LINK C DLE D 12 N BTRP D 13 1555 1555 1.33 LINK C DLE D 12 N ATRP D 13 1555 1555 1.33 LINK C BTRP D 13 N DLE D 14 1555 1555 1.33 LINK C ATRP D 13 N DLE D 14 1555 1555 1.33 LINK C DLE D 14 N TRP D 15 1555 1555 1.33 LINK C TRP D 15 N BETA D 16 1555 1555 1.32 LINK C TRP D 15 N AETA D 16 1555 1555 1.33 SITE 1 AC1 9 DVA A 6 TRP A 11 DLE A 12 DLE B 4 SITE 2 AC1 9 TRP B 9 FVA C 1 TRP C 13 HOH C2002 SITE 3 AC1 9 TRP D 9 SITE 1 AC2 5 TRP A 13 TRP C 11 DLE C 12 DLE D 4 SITE 2 AC2 5 TRP D 9 SITE 1 AC3 5 TRP A 15 ETA A 16 FVA B 1 FVA C 1 SITE 2 AC3 5 TRP C 15 CRYST1 23.960 41.981 32.429 90.00 107.25 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.041736 0.000000 0.012959 0.00000 SCALE2 0.000000 0.023820 0.000000 0.00000 SCALE3 0.000000 0.000000 0.032289 0.00000 MTRIX1 1 -0.993820 -0.080230 -0.076770 -2.15780 1 MTRIX2 1 0.049970 -0.940510 0.336060 -8.08284 1 MTRIX3 1 -0.099160 0.330140 0.938710 2.41558 1 HETATM 1 C FVA A 1 7.143 -15.331 -25.790 1.00 30.97 C HETATM 2 N FVA A 1 6.858 -14.019 -27.730 1.00 31.70 N HETATM 3 O FVA A 1 6.855 -14.376 -25.060 1.00 27.71 O HETATM 4 CA FVA A 1 7.680 -15.084 -27.194 1.00 31.28 C HETATM 5 CB FVA A 1 9.161 -14.654 -27.134 1.00 31.60 C HETATM 6 CG1 FVA A 1 10.029 -15.654 -26.353 1.00 34.78 C HETATM 7 CG2 FVA A 1 9.709 -14.490 -28.526 1.00 34.68 C HETATM 8 O1 FVA A 1 6.556 -15.008 -29.750 1.00 34.92 O HETATM 9 CN FVA A 1 6.385 -14.047 -28.981 1.00 34.39 C